Arrhythmias in the muscular dystrophies

被引:85
|
作者
Groh, William J. [1 ]
机构
[1] Indiana Univ, Dept Med, Div Cardiol, Krannert Inst Cardiol, Indianapolis, IN 46202 USA
关键词
Muscular dystrophy; Arrhythmia; Cardiomyopathy; Sudden death; Genetics; Pacemaker; Implantable cardioverter-defibrillator; CARDIAC MAGNETIC-RESONANCE; LAMIN-A/C GENE; MYOTONIC-DYSTROPHY; SUDDEN-DEATH; HEART; CARDIOMYOPATHY; SURVIVAL; TYPE-1; MECHANISMS; MORTALITY;
D O I
10.1016/j.hrthm.2012.06.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The muscular dystrophies are a group of inherited diseases affecting skeletal muscle that also affect cardiac muscle. Cardiac involvement occurs as a degenerative process with fibrosis and fatty replacement of the myocardium. Electrophysiologists are asked to participate in the care of muscular dystrophy patients because of the risk of atrial arrhythmias, conduction disease, bradycardia, ventricular arrhythmias, and sudden death. Duchenne, Becker, and limb-girdle types 2C-2F and 2I are muscular dystrophies in which the development of a dilated cardiomyopathy is common. Arrhythmias and conduction disease occur after the development of the dilated cardiomyopathy. Patients are considered for pacemakers or implantable cardioverter-defibrillators on the basis of guidelines used for nonischemic cardiomyopathies. Myotonic types 1 and 2, Emery-Dreifuss, limb-girdle type 1B, and facioscapulohumeral muscular dystrophies present with conduction disease and associated arrhythmias and variably with a dilated cardiomyopathy. In myotonic type 1, Emery-Dreifuss, and limb-girdle type 1B muscular dystrophies, conduction abnormalities are frequent and often require pacing. Recent studies support the use of prophylactic implantable cardioverter-defibrillators rather than pacemakers. In all the muscular dystrophies, respiratory muscle involvement can impact quality and quantity of life and needs to be factored in when considering a prophylactic device.
引用
收藏
页码:1890 / 1895
页数:6
相关论文
共 50 条
  • [31] Muscular dystrophies
    Veena Kalra
    The Indian Journal of Pediatrics, 2000, 67 (12) : 923 - 928
  • [32] Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure
    Cannie, Douglas E.
    Syrris, Petros
    Protonotarios, Alexandros
    Bakalakos, Athanasios
    Pruny, Jean-Francois
    Ditaranto, Raffaello
    Martinez-Veira, Cristina
    Larranaga-Moreira, Jose M.
    Medo, Kristen
    Bermudez-Jimenez, Francisco Jose
    Ben Yaou, Rabah
    Leturcq, France
    Mezcua, Ainhoa Robles
    Marini-Bettolo, Chiara
    Cabrera, Eva
    Reuter, Chloe
    Freire, Javier Limeres
    Rodriguez-Palomares, Jose F.
    Mestroni, Luisa
    Taylor, Matthew R. G.
    Parikh, Victoria N.
    Ashley, Euan A.
    Barriales-Villa, Roberto
    Jimenez-Jaimez, Juan
    Garcia-Pavia, Pablo
    Charron, Philippe
    Biagini, Elena
    Pinilla, Jose M. Garcia
    Bourke, John
    Savvatis, Konstantinos
    Wahbi, Karim
    Elliott, Perry M.
    EUROPEAN HEART JOURNAL, 2023, 44 (48) : 5064 - 5073
  • [33] Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies
    Spurney, Christopher F.
    McCaffrey, Francis M.
    Cnaan, Avital
    Morgenroth, Lauren P.
    Ghelani, Sunil J.
    Gordish-Dressman, Heather
    Arrieta, Adrienne
    Connolly, Anne M.
    Lotze, Timothy E.
    McDonald, Craig M.
    Leshner, Robert T.
    Clemens, Paula R.
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2015, 28 (08) : 999 - 1008
  • [34] Muscular dystrophies: key elements for everyday diagnosis and management
    Palladino, Alberto
    Nigro, Gerardo
    Politano, Luisa
    CARDIOGENETICS, 2013, 3 (01) : 49 - 54
  • [35] Risk of fracture in patients with muscular dystrophies
    Pouwels, S.
    de Boer, A.
    Leufkens, H. G. M.
    Weber, W. E. J.
    Cooper, C.
    van Onzenoort, H. A. W.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (02) : 509 - 518
  • [36] Mechanisms of resistance to pathogenesis in muscular dystrophies
    Juan P. Infante
    Virginia A. Huszagh
    Molecular and Cellular Biochemistry, 1999, 195 : 155 - 167
  • [37] Myotonic Dystrophies and the Heart
    Chaudhry, Sunit-Preet
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2012, 20 (01) : 1 - 3
  • [38] Heart involvement in muscular dystrophies due to sarcoglycan gene mutations
    Melacini, P
    Fanin, M
    Duggan, DJ
    Freda, MP
    Berardinelli, A
    Danieli, GA
    Barchitta, A
    Hoffman, EP
    Dalla Volta, S
    Angelini, C
    MUSCLE & NERVE, 1999, 22 (04) : 473 - 479
  • [39] Successful Heart Transplantation in Patients With Muscular Dystrophies: A Case Series
    Taghavi, Sepideh
    Naderi, Nasim
    Amin, Ahmad
    Mirtajaddini, Marzieh
    Zare, Elahe
    Chenaghlou, Maryam
    IRANIAN HEART JOURNAL, 2020, 21 (03): : 150 - 153
  • [40] Muscular Dystrophies and Other Genetic Myopathies
    Shieh, Perry B.
    NEUROLOGIC CLINICS, 2013, 31 (04) : 1009 - +